Reed Jobs Would Rather Talk About Curing Cancer Than His Last Name
When we last sat down with Jobs at TechCrunch Disrupt nearly three years ago, his firm Yosemite was brand new and biotech was still reeling from its.
Read the full articleYou might also wanna read
Reed Jobs would rather talk about curing cancer than his last name
When we last sat down with Jobs at TechCrunch Disrupt nearly three years ago, his firm Yosemite was brand new and biotech was still reeling
Reed Jobs on AI, undruggable cancer targets, and building Yosemite into a biotech powerhouse
Reed Jobs, founder of the oncology-focused venture firm Yosemite, doesn’t want to talk about his last name. He’d rather discuss Yosemite, th
Reed Jobs Focuses on Cancer Research Over Family Legacy
During a recent chat at TechCrunch Disrupt, Reed Jobs, son of the late Steve Jobs, shared insights about his evolving role in the biotech se
TechCrunch | Startup and Technology News
TechCrunch | Reporting on the business of technology, startups, venture capital funding, and Silicon Valley
techcrunch.com·13d agoIs Big Tech Now Backpedaling on the AI Jobs Wipeout Scenario?
"A year ago, the message from many business leaders was that AI was going to wipe out jobs," remembers the Wall Street Journal.But "For the
To avoid backlash, tech giants must share their AI wealth before it’s too late
The US cannot wait for the worst job losses to hit before moving corporate and public policy in a pro-worker direction
ft.com·26d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.